Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage (ABASH)

This study has been withdrawn prior to enrollment.
(Funding withdrawn. Design not feasible.)
Sponsor:
Information provided by (Responsible Party):
William J Meurer, University of Michigan
ClinicalTrials.gov Identifier:
NCT01232400
First received: November 1, 2010
Last updated: January 7, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)